Dr. Smith's ECG Blog

SEPTEMBER 12, 2024

Written by Pendell Meyers A man in his 40s called EMS for acute chest pain that awoke him from sleep, along with nausea and shortness of breath. His history included known heart failure with prior EF 18%, insulin dependent diabetes, and polysubstance abuse. Vitals were within normal limits except for tachypnea. Here are his EMS ECGs along with the Queen of Hearts interpretations below each one: EMS1 0650 EMS2 0707 Click here to sign up for Queen of Hearts Access The ECGs show RBBB and LAFB, with

Chest Pain 118

Chest Pain STEMI Cardiogenic Shock Heart Failure 118

Science Daily - Heart Disease

SEPTEMBER 12, 2024

Researchers have developed a groundbreaking smartphone app that measures blood pressure using a smartphone's built-in sensors, eliminating the need for traditional cuffs. This technology can make blood pressure monitoring more accessible and convenient, especially for underserved populations. By allowing users to measure their blood pressure anytime and anywhere, the app could revolutionize cardiovascular care and improve early detection of hypertension.

Blood Pressure 113

Blood Pressure Technology Hypertension Research 113

Medical Xpress - Cardiology

SEPTEMBER 12, 2024

Researchers at the University of Pittsburgh are pioneering a new approach to blood pressure monitoring—using the devices we carry with us every day.

Blood Pressure 100

Blood Pressure Technology Research 100

HCPLive

SEPTEMBER 12, 2024

Substitutors also reported fewer adverse events and greater social accetpance with MC.

110

110

Medical Xpress - Cardiology

SEPTEMBER 12, 2024

Cardiovascular diseases are the leading cause of mortality in Western Europe, accounting for 1/3 of deaths in 2019. Diet is thought to be responsible for around 30% of such deaths. Nutrition-related prevention policies therefore constitute a major public health challenge for these diseases.

Cardiovascular Disease 89

Cardiovascular Disease Public Health Diet 89

HeartRhythm

SEPTEMBER 12, 2024

Paced QRS morphology may vary during left bundle branch area pacing (LBBAP) as per the pacing location. It remains unclear whether electrocardiographic changes observed during LBBAP can predict clinical outcomes.

Outcomes 81

Outcomes Cardiomyopathy 81

Science Daily - Stroke

SEPTEMBER 12, 2024

In a new article, reesearchers report an increased risk of cardiovascular diseases associated with the consumption of foods that rank less favorably on the Nutri-Score scale (new 2024 version) within the European cohort EPIC.

Cardiovascular Disease 72

Cardiovascular Disease Article 72

Medical Xpress - Cardiology

SEPTEMBER 12, 2024

When a patient needs a new heart valve, the current mechanical and tissue replacements each have strengths and weaknesses. Now, a team of UBC Okanagan researchers believe they have found a way to harness the strengths of both technologies in a way that could be life-changing—and life-saving—for many. Dr. Hadi Mohammadi and his fellow researchers in the Heart Valve Performance Laboratory at UBC Okanagan are focused on developing the mechanical heart valves of the future.

Heart Valves 69

Heart Valves Technology Laboratory Research 69

NEJM Journal Watch - Cardiology

SEPTEMBER 12, 2024

Continued anticoagulation led to higher rates of bleeding than an interruption strategy, with no benefit for stroke or other thrombotic complications.

TAVR 75

TAVR Stroke Strokes 75

Journal of the American Heart Association

SEPTEMBER 12, 2024

Journal of the American Heart Association, Ahead of Print. Due to improvements in recognition and management of their multisystem disease, the long‐term survival of infants, children, and adolescents with trisomy 21 and congenital heart disease now matches children with congenital heart disease and no genetic condition in many scenarios. Although this improved survival is a triumph, individuals with trisomy 21 and congenital heart disease have unique and complex care needs in the domains of phys

Congenital Heart Disease 66

Congenital Heart Disease Congenital Heart Disease Quality of Life 66

ADN Center of Excellence

SEPTEMBER 12, 2024

We are pleased to announce the successful completion of the Coronary Intravascular Imaging Optimum: IVUS, OCT & FFR training, held in partnership with Hisar Intercontinental Hospital. This event brought together an exceptional group of medical professionals from around the world, facilitating advanced learning in coronary intravascular imaging techniques.

Hospital 59

Hospital Education Technology Cardiovascular Interventions 59

HCPLive

SEPTEMBER 12, 2024

This analysis may help to inform research evaluating the value of obstructive sleep apnea treatments designed to minimize cardiovascular risk as well as related deaths among older patients.

Research 59

Research 59

ADN Center of Excellence

SEPTEMBER 12, 2024

We are pleased to announce the successful completion of the Coronary Intravascular Imaging Optimum: IVUS, OCT & FFR training, held in partnership with Hisar Intercontinental Hospital. This event brought together an exceptional group of medical professionals from around the world, facilitating advanced learning in coronary intravascular imaging techniques.

Hospital 52

Hospital Education Technology Cardiovascular Interventions 52

HCPLive

SEPTEMBER 12, 2024

These data highlighted dupilumab’s potential as a means to break the ‘itch–scratch cycle’ in those with chronic prurigo, with disease remission induced in a subset.

59

59

Journal of Cardiothoracic Surgery

SEPTEMBER 12, 2024

It is challenging to simultaneously conduct total endovascular repair and reconstruct the left subclavian artery (LSA) and isolated left vertebral artery (ILVA) in patients who had an ILVA and required zone 2.

Stents 52

Stents Stent Research 52

HCPLive

SEPTEMBER 12, 2024

This marketing authorization by the FDA allows the Hearing Aid Feature to be implemented alongside compatible Apple AirPod Pro headphones.

64

64

Med Page Today

SEPTEMBER 12, 2024

(MedPage Today) -- Adding prophylactic left atrial appendage (LAA) closure to planned cardiac surgery was linked to lower stroke risk for patients without atrial fibrillation (Afib, or AF), based on a meta-analysis. Pooling six observational and.

AFIB 52

AFIB Atrial Fibrillation Stroke Strokes 52

HCPLive

SEPTEMBER 12, 2024

MYL-1701P showed equivalent efficacy, with comparable safety and immunogenicity, to reference aflibercept in the Phase 3 INSIGHT trial.

64

64

Becker's Hospital Review - Cardiology

SEPTEMBER 12, 2024

The American College of Cardiology and the American Heart Association's Committee on Clinical Data Standards has published guidance on the social determinants of health faced by cardiology patients. With clear definitions, these determinants can more easily be incorporated into clinical practice, the committee said in the report published Aug. 26 in the Journal of the American College of Cardiology.

52

52

HCPLive

SEPTEMBER 12, 2024

The agency's designation was granted to plozasiran as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome.

Diet 59

Diet 59

American College of Cardiology

SEPTEMBER 12, 2024

Is genotype-guided de-escalation of P2Y12 inhibitors safe and effective in a real-world acute coronary syndrome (ACS) population?

Article 65

Article 65

HCPLive

SEPTEMBER 12, 2024

Panelists discuss how JAK inhibitors and TNF inhibitors differ in administration, efficacy, and safety due to their unique characteristics and mechanisms of action, with further variations in binding activities within the TNFi class impacting clinical outcomes.

Outcomes 52

Outcomes 52

American College of Cardiology

SEPTEMBER 12, 2024

What is the evidence comparing dual antiplatelet therapy (DAPT) de-escalation to ticagrelor monotherapy versus continuing DAPT for 12 months after coronary drug-eluting stent implantation?

Stent 53

Stent Stents Article 53

HCPLive

SEPTEMBER 12, 2024

Panelists discuss how the varying selectivity of JAK inhibitors—such as tofacitinib's broad inhibition of JAK1/JAK2/JAK3, baricitinib's inhibition of JAK1/JAK2, and upadacitinib's focus on JAK1—affects dose-related toxicity and overall treatment safety.

52

52

American College of Cardiology

SEPTEMBER 12, 2024

In this special edition of Eagle’s Eye View, Dr. Eagle summarizes the most important trials that were featured at the ESC Congress 2024, August 30 to September 2—eight trials that could have significant influence on your day-to-day practice.

Article 49

Article 49

HCPLive

SEPTEMBER 12, 2024

In an interview, lead investigator Lauren Moran, MD, shared how the results inform clinical practice on safe amphetamine dosing.

59

59

Medical Xpress - Cardiology

SEPTEMBER 12, 2024

A UCLA-led research team has found that a gene mutation that affects insulin signaling in the heart may raise the risk of deadly abnormal heart rhythms in a subset of patients with cancer and could have implications for those with diabetes and obesity.

Heart Rhythm 48

Heart Rhythm Cancer Obesity Diabetes 48

HCPLive

SEPTEMBER 12, 2024

Martinez de Andino reviews key considerations for the management of DGBI with brain-gut behavioral therapy and neuromodulators.

59

59

Medical Xpress - Cardiology

SEPTEMBER 12, 2024

A coordinated, multidisciplinary health care team to address the specific physical, psychological and developmental needs of children with Trisomy 21, or Down syndrome, and congenital heart disease may help children with these conditions lead longer and more productive lives, according to a new scientific statement from the American Heart Association.

Congenital Heart Disease 45

Congenital Heart Disease Congenital Heart Disease Research 45

HCPLive

SEPTEMBER 12, 2024

A new study highlights the need for caution when prescribing high-dose amphetamines (≥ 30 mg) due to their psychosis and mania risk.

52

52

Journal of Cardiovascular Pharmacology

SEPTEMBER 12, 2024

Lipoprotein(a) [Lp(a)] is a risk factor for coronary disease. Although levels are primarily genetically determined, data from patients with inflammatory diseases indicate that the inflammatory milieu is associated with increased Lp(a) levels. Lp(a) is synthesized in the liver and the LPA gene promoter contains an interleukin-6 (IL-6) responsive binding site, but the regulatory steps linking inflammation with hepatic Lp(a) synthesis are not well clarified.

Risk Factors 40

Risk Factors 40

HCPLive

SEPTEMBER 12, 2024

Iordache reviews complications of diagnosing hepatobiliary disease in pregnancy and explains how these patients typically present.

52

52

Journal of Cardiovascular Pharmacology

SEPTEMBER 12, 2024

Atrial fibrillation (AF) poses a significant therapeutic challenge with drug interventions showing only limited success. Phosphodiesterases (PDE) regulate cardiac electrical stability and may represent an interesting target. Recently, PDE8 inhibition was proposed as an antiarrhythmic intervention by increasing L-type Ca2+ current (ICa,L) and action potential duration (APD).

Atrial Fibrillation 40

Atrial Fibrillation Article 40

HCPLive

SEPTEMBER 12, 2024

Hs-cTnT was found to be associated with a higher risk of MACE and all-cause mortality in a 10-year cohort study.

Research 52

Research 52

Journal of Cardiovascular Pharmacology

SEPTEMBER 12, 2024

Human induced pluripotent stem cells (hiPSC) and atrial hiPSC-derived cardiomyocytes (hiPSC-CM) have entered the arena of preclinical AF research. A central question is whether they reproduce the physiological contribution of atrial selective potassium currents (such as the ultrarapid potassium current, IKur) to repolarization. Of note, two studies in single atrial hiPSC-CM reported prolongation of action potential duration by IKur block indicating that IKur might in fact represent a valuable ta

Pharmacology 40

Pharmacology CMS Electrophysiology Physiology 40

HeartRhythm

SEPTEMBER 12, 2024

Traumatic brain injury (TBI) is associated with a variety of adverse long-term outcomes and increases sympathetic nervous system activation which could increase the risk of arrhythmias including atrial fibrillation or atrial flutter (AF/AFL).

Atrial Flutter 40

Atrial Flutter Atrial Fibrillation Arrhythmia Outcomes 40

The American Journal of Cardiology

SEPTEMBER 12, 2024

Publication date: Available online 12 September 2024 Source: The American Journal of Cardiology Author(s): Reza Masoomi, Kathleen E Kearney, Rhian E.

40

40